Inês Coelho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Inês Coelho has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- José Maximino Costa
Nephrology Department, Instituto Português de Oncologia do Porto, Porto, Portugal
3 shared publications Ana Paiva
Division of Nephrology, Department of Medicine, Instituto Português de Oncologia do Porto, FG, E.P.E., Porto, Portugal
2 shared publications- André Ferreira
Division of Nephrology, Department of Medicine, Instituto Português de Oncologia do Porto, FG, E.P.E., Porto, Portugal
2 shared publications - Arnaldo Figueiredo
Department of Nephrology, Urology, and Kidney Transplantation ULS‐Coimbra Coimbra Portugal
2 shared publications - Hugo Ferreira
Division of Nephrology, Department of Medicine, Instituto Português de Oncologia do Porto, FG, E.P.E., Porto, Portugal
2 shared publications Marina Reis
Division of Nephrology, Department of Medicine, Instituto Português de Oncologia do Porto, FG, E.P.E., Porto, Portugal
2 shared publications
Latest Publications
- Open Access
- 7 August 2025
- Published by Elsevier in Nefrología (English Edition)
- Vol. 45 (6) , 501332
Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality
- 7 August 2025
- Published by Elsevier in Nefrología (English Edition)
- Vol. 45 (6) , 501332
Open AccessPharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality
- Open Access
- 3 June 2025
- Published by Elsevier in Nefrología
- Vol. 45 (6)
Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality
- 3 June 2025
- Published by Elsevier in Nefrología
- Vol. 45 (6)
Open AccessPharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality
- Open Access
Severe Acute Kidney Injury in Hospitalized Cancer Patients: Epidemiology and Predictive Model of Renal Replacement Therapy and In-Hospital Mortality
Background: Acute kidney injury (AKI) is a common complication among cancer patients, often leading to longer hospital stays, discontinuation of cancer treatment, and a poor prognosis. This study aims to provide insight into the incidence of severe AKI in this population and identify the risk factors associated with renal replacement therapy (RRT) and in-hospital mortality. Methods: This retrospective cohort study included 3201 patients with cancer and severe AKI admitted to a Comprehensive Cancer Center between January 1995 and July 2023. Severe AKI was defined according to the KDIGO guidelines as grade ≥ 2 AKI with nephrological in-hospital follow-up. Data were analyzed in two timelines: Period A (1995–2010) and Period B (2011–2023). Results: A total of 3201 patients (1% of all hospitalized cases) were included, with a mean age of 62.5 ± 17.2 years. Solid tumors represented 75% of all neoplasms, showing an increasing tendency, while hematological cancer decreased. Obstructive AKI declined, whereas the incidence of sepsis-associated, prerenal, and drug-induced AKI increased. Overall, 20% of patients required RRT, and 26.4% died during hospitalization. A predictive model for RRT (AUC 0.833 [95% CI 0.817–0.848]) identified sepsis and hematological cancer as risk factors and prerenal and obstructive AKI as protective factors. A similar model for overall in-hospital mortality (AUC 0.731 [95% CI 0.71–0.752]) revealed invasive mechanical ventilation (IMV), sepsis, and RRT as risk factors and obstructive AKI as a protective factor. The model for hemato-oncological patients’ mortality (AUC 0.832 [95% CI 0.803–0.861]) included IMV, sepsis, hematopoietic stem cell transplantation, and drug-induced AKI. Mortality risk point score models were derived from these analyses. Conclusions: This study addresses the demographic and clinical features of cancer patients with severe AKI. The development of predictive models for RRT and in-hospital mortality, along with risk point scores, may play a role in the management of this population.
Open AccessSevere Acute Kidney Injury in Hospitalized Cancer Patients: Epidemiology and Predictive Model of Renal Replacement Therapy and In-Hospital Mortality
Background: Acute kidney injury (AKI) is a common complication among cancer patients, often leading to longer hospital stays, discontinuation of cancer treatment, and a poor prognosis. This study aims to provide insight into the incidence of severe AKI in this population and identify the risk factors associated with renal replacement therapy (RRT) and in-hospital mortality. Methods: This retrospective cohort study included 3201 patients with cancer and severe AKI admitted to a Comprehensive Cancer Center between January 1995 and July 2023. Severe AKI was defined according to the KDIGO guidelines as grade ≥ 2 AKI with nephrological in-hospital follow-up. Data were analyzed in two timelines: Period A (1995–2010) and Period B (2011–2023). Results: A total of 3201 patients (1% of all hospitalized cases) were included, with a mean age of 62.5 ± 17.2 years. Solid tumors represented 75% of all neoplasms, showing an increasing tendency, while hematological cancer decreased. Obstructive AKI declined, whereas the incidence of sepsis-associated, prerenal, and drug-induced AKI increased. Overall, 20% of patients required RRT, and 26.4% died during hospitalization. A predictive model for RRT (AUC 0.833 [95% CI 0.817–0.848]) identified sepsis and hematological cancer as risk factors and prerenal and obstructive AKI as protective factors. A similar model for overall in-hospital mortality (AUC 0.731 [95% CI 0.71–0.752]) revealed invasive mechanical ventilation (IMV), sepsis, and RRT as risk factors and obstructive AKI as a protective factor. The model for hemato-oncological patients’ mortality (AUC 0.832 [95% CI 0.803–0.861]) included IMV, sepsis, hematopoietic stem cell transplantation, and drug-induced AKI. Mortality risk point score models were derived from these analyses. Conclusions: This study addresses the demographic and clinical features of cancer patients with severe AKI. The development of predictive models for RRT and in-hospital mortality, along with risk point scores, may play a role in the management of this population.
- Open Access
- 3 May 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 44 (3) , 457-461
Presumed cytomegalovirus retinitis late after kidney transplant
Cytomegalovirus (CMV) retinitis is a rare manifestation of CMV invasive disease and potentially threatening to vision in immunocompromised individuals. Clinical suspicion is fundamental since it is an unusual entity with a progressive and often asymptomatic installation over a long period. The authors report a 70-year-old man with diabetic nephropathy who underwent a kidney transplant (KT) in August 2014 with good clinical evolution. No previous CMV infection or episodes of acute rejection were reported. Five years after transplant, he was admitted due to a reduced visual acuity of the left eye with seven days of evolution with associated hyperemia, without exudate. The ophthalmologic evaluation was compatible with acute necrosis of the retina and presumed associated with CMV infection. He had a progressive improvement after ganciclovir initiation. CMV retinitis is one of the most serious ocular complications in immune-suppressed individuals and can lead to irreversible blindness, and because of that, early diagnosis and treatment remains crucial in obtaining the best visual prognosis in affected patients. Secondary prophylaxis with ganciclovir is not consensual, neither is the safety of reintroducing the antimetabolite in these cases.
- 3 May 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 44 (3) , 457-461
Open AccessPresumed cytomegalovirus retinitis late after kidney transplant
Cytomegalovirus (CMV) retinitis is a rare manifestation of CMV invasive disease and potentially threatening to vision in immunocompromised individuals. Clinical suspicion is fundamental since it is an unusual entity with a progressive and often asymptomatic installation over a long period. The authors report a 70-year-old man with diabetic nephropathy who underwent a kidney transplant (KT) in August 2014 with good clinical evolution. No previous CMV infection or episodes of acute rejection were reported. Five years after transplant, he was admitted due to a reduced visual acuity of the left eye with seven days of evolution with associated hyperemia, without exudate. The ophthalmologic evaluation was compatible with acute necrosis of the retina and presumed associated with CMV infection. He had a progressive improvement after ganciclovir initiation. CMV retinitis is one of the most serious ocular complications in immune-suppressed individuals and can lead to irreversible blindness, and because of that, early diagnosis and treatment remains crucial in obtaining the best visual prognosis in affected patients. Secondary prophylaxis with ganciclovir is not consensual, neither is the safety of reintroducing the antimetabolite in these cases.
- 1 June 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (5) , 1618-1620
A Rare Manifestation of Tuberculosis in a Renal Transplant Patient: A Case Report
- 1 June 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (5) , 1618-1620
A Rare Manifestation of Tuberculosis in a Renal Transplant Patient: A Case Report
- 22 January 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (1) , e228413
Spontaneous subcapsular haematoma: a rare cause of acute kidney graft dysfunction
A 39-year-old patient who had kidney transplant presented at the emergency department with pain in his right flank that was ongoing for 15 days. It had started suddenly when he was driving his taxi, after a coughing effort. No haematuria and no history of trauma. He had had a deceased donor kidney
- 22 January 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (1) , e228413
Spontaneous subcapsular haematoma: a rare cause of acute kidney graft dysfunction
A 39-year-old patient who had kidney transplant presented at the emergency department with pain in his right flank that was ongoing for 15 days. It had started suddenly when he was driving his taxi, after a coughing effort. No haematuria and no history of trauma. He had had a deceased donor kidney
- Open Access
- 30 May 2016
- Published by Taylor & Francis in Revista Portuguesa de Pneumologia (English Edition)
- Vol. 22 (3) , 180-181
Integrated domiciliary ventilation outpatient clinic – Description and experience of an integrated and multidisciplinary model
- 30 May 2016
- Published by Taylor & Francis in Revista Portuguesa de Pneumologia (English Edition)
- Vol. 22 (3) , 180-181
Open AccessIntegrated domiciliary ventilation outpatient clinic – Description and experience of an integrated and multidisciplinary model